Company: LBRX
Filing Date: 2025-09-10
Form Type: 3
Source: 0001415889-25-024175
Chunk: 1

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-10
Form: 3
Chunk 1
---
 |     |   |
| Stock Option (Right to Buy)                |                                                   $69.72 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F2] - 06/26/2028 | Common Stock - 1,792  | N/A | N/A | D |
| Stock Option (Right to Buy)                |                                                   $69.72 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F2] - 08/24/2030 | Common Stock - 717    | N/A | N/A | D |
| Stock Option (Right to Buy)                |                                                   $41.84 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F3] - 03/03/2034 | Common Stock - 10,757 | N/A | N/A | D |

| ** Signature of Reporting Person      
 /s/ /s/ Marc Panoff, Attorney-in-Fact | Date       
 09/10/2025 |

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. 
 Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.